Lessons learnt about early prostate cancer from large scale databases: Population-based pearls of wisdom

Surgical Oncology

Volumn 11, Issue 1-2, 2002, Pages 3-11

  Penson, David F ^a   Albertsen, Peter C ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Methodology; Population based studies; Prostate cancer; Treatment

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL TRIAL; COMORBIDITY; CONSERVATIVE TREATMENT; DATA BASE; EARLY CANCER; HEALTH MAINTENANCE ORGANIZATION; HUMAN; METHODOLOGY; PATIENT COUNSELING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RACE DIFFERENCE; RISK ASSESSMENT; TREATMENT OUTCOME;

CLINICAL TRIALS; CONTINENTAL POPULATION GROUPS; DATABASES, FACTUAL; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; PROSTATIC NEOPLASMS; SEER PROGRAM; TREATMENT OUTCOME; UNITED STATES; UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;

EID: 0036269413     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(02)00009-9     Document Type: Article

References (50)

1. Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years
2. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years
3. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies
4. Radical surgery versus radiotherapy for adenocarcinoma of the prostate
5. Randomized series of treatment with surgery versus radiation for prostate adenocarcinoma
6. Screening decreases prostate cancer death: First analysis of the 1988 Quebec prospective randomized controlled trial
7. The prostate cancer intervention versus observation trial (PIVOT)
8. Measuring the incidence of cancer in elderly Americans using Medicare claims data
9. Para-analysis, faute de mieux, and the perils of riding the data barge
10. Accuracy of diagnostic coding for Medicare patients under the prospective-payment system
11. Internal validation of Medicare claims data
12. Potential for cancer-related health services research using a linked Medicare-tumor registry database
13. Development of a comorbidity index using physician claims data
14. US Department of Veterans Affairs medical care system as a resource to epidemiologists
15. Statistical considerations when assessing outcomes following treatment for prostate cancer
16. High 10-year survival rate in patients with early, untreated prostatic cancer
17. Natural history of localised prostatic cancer A population-based study in 223 untreated patients
18. Long-term survival among men with conservatively treated localized prostate cancer
19. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
20. Is race an independent prognostic factor for survival from prostate cancer?
21. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening
22. Race and the Will Rogers phenomenon in prostate cancer
23. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting
24. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men
25. Partitioned prostate cancer prevalence estimates: An informative measure of the disease burden
26. Estimating the prevalence of cancer in the United States
27. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate
28. Prostate cancer: Trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States)
29. Factors that determine the treatment for local and regional prostate cancer
30. Radical prostatectomy: Lower rates among African-American men
31. Mortality in prostate cancer
32. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987
33. Differences in socioeconomic status and survival among white and black men with prostate cancer
34. Race, prostate cancer survival, and membership in a large health maintenance organization
35. Ethnic variation in prostate cancer survival in New Mexico
36. Population-based prostate cancer trends in the United States: Patterns of change in the era of prostate-specific antigen
37. An assessment of radical prostatectomy. Time trends geographic variation and outcomes. The prostate patient outcomes research team
38. Changes in prostate cancer incidence and treatment in USA
39. Overall and disease-specific survival after radical prostatectomy: Geographic uniformity
40. Trends in the use of radical prostatectomy for treatment of prostate cancer
41. Population-based study of long-term survival in patients with clinically localised prostate cancer
42. Follow-up prostate cancer treatments after radical prostatectomy: A population-based study
43. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993)
44. Mortality of patients after radical prostatectomy: Analysis of recent Medicare claims
45. Effect of radical prostatectomy for prostate cancer on patient quality of life: Results from a Medicare survey
46. Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas
47. Prostate cancer practice patterns and quality of life: The Prostate Cancer Outcomes Study
48. Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study